文献速递冠心病血脂与心血管预防

COVID-19合并STEMI患者血栓负荷增高

High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2020-07-14

这项单中心观察性研究纳入2020年3月1日至5月20日在Barts心脏中心连续收治的115例确诊STEMI并接受直接PCI的患者,比较COVID-19阳性与阴性者的造影特征和临床结局。结果显示,合并COVID-19的STEMI患者血栓负荷更高、心肌灌注和左室功能更差、住院和ICU入住率更高。

要点

  • COVID-19合并STEMI患者多支血栓、支架血栓及首次器械后血栓分级更高。
  • 该类患者心肌灌注分级和左室功能显著更低,住院及ICU入住率更高。
  • 所有STEMI患者均应检测COVID-19状态,以识别高血栓负荷风险。

核心结论

  • 合并COVID-19感染的STEMI患者表现出更强的血栓负荷信号和更差的结局。

研究设计与样本

  • 单中心观察性研究,连续纳入2020年3月1日至5月20日在Barts心脏中心确诊STEMI并接受直接PCI的115例患者。

主要发现

  • COVID-19阳性STEMI患者肌钙蛋白T和D-二聚体、C反应蛋白升高,淋巴细胞计数降低。
  • COVID-19阳性患者多支血栓、支架血栓、首次器械后改良血栓分级更高,糖蛋白IIb/IIIa抑制剂和血栓抽吸使用更多。
  • COVID-19阳性患者心肌灌注分级和左室功能显著更低,达到治疗性活化凝血时间所需肝素剂量更高。
  • COVID-19阳性患者住院时间更长,ICU入住率更高。

临床怎么用

  • 对所有STEMI病例应明确COVID-19状态。
  • 对合并COVID-19的STEMI患者需警惕高血栓负荷,可考虑更积极抗栓策略但需进一步研究。

局限性

  • 单中心观察性研究,样本量有限,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronavirus disease-2019 (COVID-19) is thought to predispose patients to thrombotic disease. To date there are few reports of ST-segment elevation myocardial infarction (STEMI) caused by type 1 myocardial infarction in patients with COVID-19. OBJECTIVES: The aim of this study was to describe the demographic, angiographic, and procedural characteristics alongside clinical outcomes of consecutive cases of COVID-19-positive patients with STEMI compared with COVID-19-negative patients. METHODS: This was a single-center, observational study of 115 consecutive patients admitted with confirmed STEMI treated with primary percutaneous coronary intervention at Barts Heart Centre between March 1, 2020, and May 20, 2020. RESULTS: Patients with STEMI presenting with concurrent COVID-19 infection had higher levels of troponin T and lower lymphocyte count, but elevated D-dimer and C-reactive protein. There were significantly higher rates of multivessel thrombosis, stent thrombosis, higher modified thrombus grade post first device with consequently higher use of glycoprotein IIb/IIIa inhibitors and thrombus aspiration. Myocardial blush grade and left ventricular function were significantly lower in patients with COVID-19 with STEMI. Higher doses of heparin to achieve therapeutic activated clotting times were also noted. Importantly, patients with STEMI presenting with COVID-19 infection had a longer in-patient admission and higher rates of intensive care admission. CONCLUSIONS: In patients presenting with STEMI and concurrent COVID-19 infection, there is a strong signal toward higher thrombus burden and poorer outcomes. This supports the need for establishing COVID-19 status in all STEMI cases. Further work is required to understand the mechanism of increased thrombosis and the benefit of aggressive antithrombotic therapy in selected cases.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Choudry FA, Hamshere SM, Rathod KS, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020. PMID: 32679155. doi:10.1016/j.jacc.2020.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。